0000878088-12-000016.txt : 20120109 0000878088-12-000016.hdr.sgml : 20120109 20120109182012 ACCESSION NUMBER: 0000878088-12-000016 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120105 FILED AS OF DATE: 20120109 DATE AS OF CHANGE: 20120109 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Campanelli Paul CENTRAL INDEX KEY: 0001392459 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-10827 FILM NUMBER: 12518446 MAIL ADDRESS: STREET 1: C/O PAR PHARMACEUTICAL COMPANIES, INC. STREET 2: 300 TICE BOULEVARD CITY: WOODCLIFF LAKE STATE: NJ ZIP: 07677 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PAR PHARMACEUTICAL COMPANIES, INC. CENTRAL INDEX KEY: 0000878088 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 223122182 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 300 TICE BOULEVARD CITY: WOODCLIFF LAKE STATE: NJ ZIP: 07677 BUSINESS PHONE: 201-802-4000 MAIL ADDRESS: STREET 1: 300 TICE BOULEVARD CITY: WOODCLIFF LAKE STATE: NJ ZIP: 07677 FORMER COMPANY: FORMER CONFORMED NAME: PHARMACEUTICAL RESOURCES INC DATE OF NAME CHANGE: 19940526 4 1 primary_doc.xml PRIMARY DOCUMENT X0304 4 2012-01-05 0 0000878088 PAR PHARMACEUTICAL COMPANIES, INC. PRX 0001392459 Campanelli Paul C/O PAR PHARMACEUTICAL COMPANIES, INC. 300 TICE BOULEVARD WOODCLIFF LAKE NJ 07677 0 1 0 0 Chief Operating Officer Common Stock 2012-01-06 4 F 0 806 34.01 D 47118 D Restricted Stock Units 2012-01-05 4 A 0 25438 0 A 2016-01-05 2016-01-05 Common Stock 25438 25438 D Common Stock, Option to Buy 32.76 2012-01-05 4 A 0 50875 0 A 2022-01-04 Common Stock 50875 50875 D Performance Stock Units 2012-01-05 4 A 0 25438 0 A Common Stock 25438 25438 D Surrender of shares in payment of tax withholding due as a result of the vesting of Restricted Stock granted in accordance with Rule 16b-3. Includes (i) 31,543 shares of Common Stock, and (ii) 15,575 shares of Restricted Stock held by Mr. Campanelli. Award of Restricted Stock Units (RSUs) under the Company's 2004 Performance Equity Plan, which RSUs vest on the fourth anniversary of the date of grant (1/5/2016). Each RSU will be convertible into one share of the Company's Common Stock on 1/5/2016. Award of Option to purchase shares of Common Stock under the Company's 2004 Performance Equity Plan. 25% vest on the first anniversary of the date of grant and an additional 25% vest on each anniversary until fully vested. Award of Performance Stock Units (PSUs) under the Company's 2004 Performance Equity Plan, which PSUs vest only upon the achievement of certain predetermined financial, operational and strategic goals over a three-year period. Each PSU will be convertible into one share of the Company's Common Stock upon vesting. /s/ Marian E. Gustafson for Paul V. Campanelli 2012-01-09